Investment Areas
Codon Capital’s focus is in two biology disciplines, Therapeutics and Synthetic Biology, each with unique investment benefits. Together, they represent the new “biology design revolution,” opportunities that will define healthcare, agriculture, and more during this decade.
Therapeutics
Our Therapeutics investments are sourced to meet the following criteria:
|
Synthetic Biology
Attractive Synthetic Biology opportunities:
|